Ephrin A1 ligand‐based CAR‐T cells for immunotherapy of EphA2‐positive cancer
Abstract Chimeric antigen receptor (CAR) T cells have demonstrated promising results in hematological malignancies; however, challenges remain in treating solid tumors. New CARs with more effectiveness and lower side effects are needed. Ephrin type‐A receptor 2 (EphA2) belongs to the Ephrin family o...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | MedComm – Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/mog2.70010 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|